93 related articles for article (PubMed ID: 25156855)
1. Regular dipyridamole therapy produces sustained protection against cardiac ischemia-reperfusion injury: is it time to revisit PARIS?
Figueredo VM; Okusa C; Kaneda K; Inamura Y; Miyamae M
Int J Cardiol; 2014 Oct; 176(3):822-7. PubMed ID: 25156855
[TBL] [Abstract][Full Text] [Related]
2. Chronic dipyridamole therapy produces sustained protection against cardiac ischemia-reperfusion injury.
Figueredo VM; Diamond I; Zhou HZ; Camacho SA
Am J Physiol; 1999 Nov; 277(5):H2091-7. PubMed ID: 10564165
[TBL] [Abstract][Full Text] [Related]
3. Sevoflurane enhances ethanol-induced cardiac preconditioning through modulation of protein kinase C, mitochondrial KATP channels, and nitric oxide synthase, in guinea pig hearts.
Kaneda K; Miyamae M; Sugioka S; Okusa C; Inamura Y; Domae N; Kotani J; Figueredo VM
Anesth Analg; 2008 Jan; 106(1):9-16, table of contents. PubMed ID: 18165545
[TBL] [Abstract][Full Text] [Related]
4. Preconditioning with acute and chronic lithium administration reduces ischemia/reperfusion injury mediated by cyclooxygenase not nitric oxide synthase pathway in isolated rat heart.
Faghihi M; Mirershadi F; Dehpour AR; Bazargan M
Eur J Pharmacol; 2008 Nov; 597(1-3):57-63. PubMed ID: 18789320
[TBL] [Abstract][Full Text] [Related]
5. Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination.
Ye Y; Lin Y; Perez-Polo R; Huang MH; Hughes MG; McAdoo DJ; Manickavasagam S; Uretsky BF; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H813-8. PubMed ID: 17416607
[TBL] [Abstract][Full Text] [Related]
6. Effect of desflurane-induced preconditioning following ischemia-reperfusion on nitric oxide release in rabbits.
Tsai SK; Lin SM; Huang CH; Hung WC; Chih CL; Huang SS
Life Sci; 2004 Dec; 76(6):651-60. PubMed ID: 15567190
[TBL] [Abstract][Full Text] [Related]
7. Clematichinenoside attenuates myocardial infarction in ischemia/reperfusion injury both in vivo and in vitro.
Zhang R; Fang W; Han D; Sha L; Wei J; Liu L; Li Y
Planta Med; 2013 Sep; 79(14):1289-97. PubMed ID: 23929248
[TBL] [Abstract][Full Text] [Related]
8. Effects of acute and chronic atorvastatin on cardioprotection of ischemic postconditioning in isolated rat hearts.
Fan Y; Yang S; Cao Y; Huang Y
Cardiovasc Ther; 2013 Aug; 31(4):187-92. PubMed ID: 22954178
[TBL] [Abstract][Full Text] [Related]
9. Catalpol decreases peroxynitrite formation and consequently exerts cardioprotective effects against ischemia/reperfusion insult.
Huang C; Cui Y; Ji L; Zhang W; Li R; Ma L; Xing W; Zhou H; Chen B; Yu J; Zhang H
Pharm Biol; 2013 Apr; 51(4):463-73. PubMed ID: 23336403
[TBL] [Abstract][Full Text] [Related]
10. Insulin protects isolated hearts from ischemia/reperfusion injury: cross-talk between PI3-K/Akt and JNKs.
Liu HT; Zhang HF; Si R; Zhang QJ; Zhang KR; Guo WY; Wang HC; Gao F
Sheng Li Xue Bao; 2007 Oct; 59(5):651-9. PubMed ID: 17940706
[TBL] [Abstract][Full Text] [Related]
11. Protecting against ischemia-reperfusion injury: antiplatelet drugs, statins, and their potential interactions.
Ye Y; Perez-Polo JR; Birnbaum Y
Ann N Y Acad Sci; 2010 Oct; 1207():76-82. PubMed ID: 20955429
[TBL] [Abstract][Full Text] [Related]
12. Gender-related difference of sevoflurane postconditioning in isolated rat hearts: focus on phosphatidylinositol-3-kinase/Akt signaling.
Zheng Z; Yang M; Zhang F; Yu J; Wang J; Ma L; Zhong Y; Qian L; Chen G; Yu L; Yan M
J Surg Res; 2011 Sep; 170(1):e3-9. PubMed ID: 21704330
[TBL] [Abstract][Full Text] [Related]
13. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.
Sun Z; Tong G; Ma N; Li J; Li X; Li S; Zhou J; Xiong L; Cao F; Yao L; Wang H; Shen L
Basic Res Cardiol; 2013 May; 108(3):341. PubMed ID: 23463182
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of ligustrazine against myocardial ischaemia reperfusion in rats: the role of endothelial nitric oxide synthase.
Lv L; Jiang SS; Xu J; Gong JB; Cheng Y
Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):20-7. PubMed ID: 22004361
[TBL] [Abstract][Full Text] [Related]
16. Preconditioning with periodic acceleration (pGz) provides second window of cardioprotection.
Uryash A; Wu H; Bassuk J; Kurlansky P; Adams JA
Life Sci; 2012 Sep; 91(5-6):178-85. PubMed ID: 22789658
[TBL] [Abstract][Full Text] [Related]
17. Hypercholesterolemia abrogates sevoflurane-induced delayed preconditioning against myocardial infarct in rats by alteration of nitric oxide synthase signaling.
Zhang FJ; Ma LL; Wang WN; Qian LB; Yang MJ; Yu J; Chen G; Yu LN; Yan M
Shock; 2012 May; 37(5):485-91. PubMed ID: 22266969
[TBL] [Abstract][Full Text] [Related]
18. Dipyridamole with low-dose aspirin augments the infarct size-limiting effects of simvastatin.
Ye Y; Long B; Qian J; Perez-Polo JR; Birnbaum Y
Cardiovasc Drugs Ther; 2010 Dec; 24(5-6):391-9. PubMed ID: 20640495
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
Gonon AT; Widegren U; Bulhak A; Salehzadeh F; Persson J; Sjöquist PO; Pernow J
Cardiovasc Res; 2008 Apr; 78(1):116-22. PubMed ID: 18222959
[TBL] [Abstract][Full Text] [Related]
20. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
Ferdinandy P; Schulz R; Baxter GF
Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
